Skip to content
  • CAT
  • ESP
  • ENG
  • About us
  • Contact
El·lipse
  • instagram
  • twitter
  • flickr
  • linkdin
  • facebook
  • youtube
  • Research
  • Public engagement
  • Scientific life
  • Community
  • About us
  • Contact
  • instagram
  • twitter
  • flickr
  • linkdin
  • facebook
  • youtube
  • CAT
  • ESP
  • ENG

Coronavirus

22.02.2021

Down Syndrome, a high risk factor for COVID-19

17.02.2021

Light at the end of the tunnel… or between the blinds

17.02.2021

A clinical trial to verify the effectiveness of a new drug against COVID-19

Els investigadors de l'IMIM Gemma Vilagut, Jordi Alonso, Philippe Mortier i Víctor Pérez han dut a terme aquest estudi.
01.02.2021

The impact of the pandemic on the mental wellbeing of health professionals

29.01.2021

Ivermectin could reduce viral transmission of COVID-19

14.01.2021

The effects of the pandemic on mental health and social inequalities, in the spotlight

21.12.2020

Susceptibility to COVID-19 analyzed in ten animal species

17.12.2020

How do the COVID-19 vaccines work?

02.12.2020

SARS-Cov-2 antibodies detected three months after the infection

Organoid images will be key to studying the effect of infection. Image by Sandra Acosta, IBE.
17.11.2020

Human organoids to study COVID-19 infection and treatments more realistically

Some treatments against osteoporosis could interfere with SARS-Cov-2 infection. Image created by Mario Ejarque from images by Owen Beard and Tonik via Unsplash.
11.11.2020

The main treatments of osteoporosis could offer protection against COVID-19

Detection of two heart damage markers could be used to make a prognosis of COVID-19 patients' evolution. Image by Mario Ejarque from images by Debby Hudson and CDC on Unsplash
26.10.2020

Heart damage markers to predict the evolution of COVID-19 patients

El·lipse is published by the PRBB Communications and Corporate Relations Area.

Dr Aiguader, 88, 08003 Barcelona, Spain

For any suggestions or collaborations please contact us at ellipse@prbb.org

  • Read past print editions
  • About El·lipse
  • About the PRBB
  • Legal disclaimer
  • instagram
  • twitter
  • flickr
  • linkdin
  • facebook
  • youtube
© 2026 El·lipse, PRBB
  • Home
  • News
  • Our picks
This website uses cookies that provide us with personal information, such as data associated with your browsing. If you click on I AGREE, both we and our Partners can install cookies or access non-sensitive information on your device in order to facilitate the reproduction of content, provide features on social networks, create profiles and compile statistics on traffic and usability in our website. You can get MORE INFORMATION by accessing our COOKIES POLICY. I agree More information
Privacy & Cookies Policy

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.
Necessary
Always Enabled
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Non-necessary
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.
SAVE & ACCEPT
Subscribe to our mailing list
Want to be the first to know everything that goes on at the biggest biomedical research hub in Southern Europe? Subscribe to the el·lipse newsletter!

We will send you an email with the latest news.

See you soon!

*Required field

Field is not valid
You have to authorize data treatment

At any time, you can exercise the rights of access, rectification, opposition, portability, limitation to treatment and deletion of the data subject to treatment by clicking on the links "Update data" and "Unsubscribe", sending a letter indicating the right exercised to the postal address indicated at the bottom or to the following email address ellipse@prbb.org